1. The Role of Inflammasome in Cancers and Potential Therapeutic Targets
   Pooya Farhangnia et al, 2023, Handbook of Cancer and Immunology CrossRef
2. A multicenter, phase 1, dose escalation clinical trial (G-FORCE-1) of XRT, RRx-001 and temozolomide followed by temozolomide +/- RRx-001 in newly diagnosed glioblastoma
   Howard Fine et al, 2023, Frontiers in Oncology CrossRef
3. Levosimendan Protects against Doxorubicin-Induced Cardiotoxicity by Regulating the PTEN/Akt Pathway
   Ling-Li Li et al, 2020, BioMed Research International CrossRef
4. Role of RAGE and Its Ligands on Inflammatory Responses to Brain Tumors
   Griffith Kyle Otazu et al, 2021, Frontiers in Cellular Neuroscience CrossRef
5. Classification related to immunogenic cell death predicts prognosis, immune microenvironment characteristics, and response to immunotherapy in lower-grade gliomas
   Yirui Kuang et al, 2023, Frontiers in Immunology CrossRef
6. Zerumbone Suppresses the LPS-Induced Inflammatory Response and Represses Activation of the NLRP3 Inflammasome in Macrophages
   Chia-Cheng Su et al, 2021, Frontiers in Pharmacology CrossRef
7. IP-Se-06, a Selenylated Imidazo[1,2-a]pyridine, Modulates Intracellular Redox State and Causes Akt/mTOR/HIF-1α and MAPK Signaling Inhibition, Promoting Antiproliferative Effect and Apoptosis in Glioblastoma Cells
   Daniela C. dos Santos et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
8. Paeoniflorin Inhibits EMT and Angiogenesis in Human Glioblastoma via K63-Linked C-Met Polyubiquitination-Dependent Autophagic Degradation
   Zhi Liu et al, 2022, Frontiers in Oncology CrossRef
9. Calycosin (CA) inhibits proliferation, migration and invasion by suppression of CXCL10 signaling pathway in glioma
   Xiaoyu Zheng et al, 2024, Aging CrossRef
10. Discovery of a novel rhein-SAHA hybrid as a multi-targeted anti-glioblastoma drug
    Jingkao Chen et al, 2020, Investigational New Drugs CrossRef
11. Resveratrol ameliorates glioblastoma inflammatory response by reducing NLRP3 inflammasome activation through inhibition of the JAK2/STAT3 pathway
    Chao Zhang et al, 2024, Journal of Cancer Research and Clinical Oncology CrossRef
12. Therapeutic Potential of Pharmacological Targeting NLRP3 Inflammasome Complex in Cancer
    Gulcin Tezcan et al, 2021, Frontiers in Immunology CrossRef
13. The Multifaceted Roles of Pyroptotic Cell Death Pathways in Cancer
    Man Wang et al, 2019, Cancers CrossRef
14. Upregulation of the NLRC4 inflammasome contributes to poor prognosis in glioma patients
    Jaejoon Lim et al, 2019, Scientific Reports CrossRef
15. Preparation and Gas Sensing Properties of Hair-Based Carbon Sheets
    Zhaofeng Wu et al, 2022, Nanomaterials CrossRef
16. NLRP3 Overexpression Associated With Poor Prognosis and Presented as an Effective Therapeutic Target in Osteosarcoma
    Zhen Huang et al, 2021, Frontiers in Pharmacology CrossRef
17. Prognostic Value of NLRP3 Inflammasome and TLR4 Expression in Breast Cancer Patients
    Concetta Saponaro et al, 2021, Frontiers in Oncology CrossRef
18. Dysregulation of inflammasome activation in glioma
    JeongMin Sim et al, 2023, Cell Communication and Signaling CrossRef
19. Reversal of Epithelial–Mesenchymal Transition by Natural Anti-Inflammatory and Pro-Resolving Lipids
    null Lee, 2019, Cancers CrossRef
20. Targeting the NLRP3 Inflammasome as a New Therapeutic Option for Overcoming Cancer
    Sonia Missiroli et al, 2021, Cancers CrossRef
21. Role of the NLRP3 Inflammasome: Insights Into Cancer Hallmarks
    Ting-Yi Lin et al, 2021, Frontiers in Immunology CrossRef